Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Second-line afatinib significantly improves PFS in metastatic head and neck...

Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium

Second-line afatinib significantly improves PFS in metastatic head and neck cancer ( Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium )

Networking and collaborating across borders in sub-Saharan Africa

Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...

Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid...

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Lapatinib not found to be beneficial in head and neck cancer with high risk of...

Prof Kevin Harrington - Institute of Cancer Research, London, UK

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )

Lenvatinib yields high response rates and delays progression in radioiodine...

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France

Lenvatinib yields high response rates and delays progression in radioiodine-resistant, advanced differentiated thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )

Phase II trial shows dacomitinib benefits a subgroup of patients with head and...

Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of...

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

The relationship between obesity and cancer, and other dietary factors

Dr Walter C. Willett - Harvard School of Public Health, Boston, USA

The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )

ecancermedicalscience Editor's Choice: Robotic surgery in oncology

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice: Robotic surgery in oncology ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Stem cell therapy for prevention of radiation-induced salivary gland toxicity

Dr Rob Coppes - University of Groningen, Netherlands

Stem cell therapy for prevention of radiation-induced salivary gland toxicity ( Dr Rob Coppes - University of Groningen, Netherlands )

More from ecancer